A recent scientific breakthrough has emerged from the work of researchers aiming to combat SARS-CoV-2, the virus responsible for COVID-19. The study focuses on the design and development of a novel ...
According to Brazilian researchers, SARS-CoV-2 uses this strategy to manipulate the machinery of the host’s defense cells. The discovery paves the way for the development of novel therapies. To evade ...
Vials of Novavax Covid-19 vaccines arranged at a pharmacy in Schwenksville, Pennsylvania, US, on Monday, Aug. 1, 2022. Novavax's protein-based Covid-19 vaccine received long-sought US emergency-use ...
Although COVID-19 has faded from the headlines, SARS-CoV-2 – the coronavirus behind the pandemic – is still rampantly infecting people around the world. Public health officials fear as the virus ...
Hosted on MSN
Key human proteins that power coronavirus replication point to new treatment strategies
Despite vaccines and treatments, SARS-CoV-2—the virus that causes COVID-19—continues to pose a global health threat, driven by new variants and its ability to hijack human cells in ways that still ...
A new oral drug developed by researchers at Stanford University may be superior to Pfizer’s Paxlovid at reducing the severity of COVID-19, at least in mice. In a study published March 13 in Science ...
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine New antiviral drugs in development could offer the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results